EGFR and glioblastoma: LncRNA-NEAT1 has been revealed to be modulated by the epidermal growth factor receptor (EGFR) pathway, leading to glioblastoma multiform progression by the WNT/β-Catenin Pathway by Scaffolding enhancer of zeste homolog 2 (EZH2) [13].